Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to UY26382ApriorityCriticalpatent/UY26382A1/en
Publication of UY26382A1publicationCriticalpatent/UY26382A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a sales anhidras del ácido paratolueno sulfónico de 3-etil-5-(5-(4-etilpiperazin-1-ilsulfonil)-2-(2-metoxietoxi)piridin-3-Il)-2-(piridin -2- IL) metil -2,6-dihidro-7H-pirazolo- (4,3-d) pirimidin -7-ona, que tienen la fórmula (I): un procedimiento para preparar los compuestos (I), composiciones farmacéuticas que contienen (I) y uso de (I) en medicina.The invention relates to anhydrous salts of 3-ethyl-5- (5- (4-ethylpiperazin-1-ylsulfonyl) -2- (2-methoxyethoxy) pyridin-3-Il) -2- (pyridine - paratoluene sulfonic acid). 2- IL) methyl -2,6-dihydro-7H-pyrazolo- (4,3-d) pyrimidin -7-one, having the formula (I): a process for preparing compounds (I), pharmaceutical compositions which contain (I) and use of (I) in medicine.
DERIVATIVES OF BENZOCONDENSED HETEROARILAMIDE OF USEFUL TIENOPIRIDINS AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE SAME AND METHODS FOR USE
COMPLEXES OF E-2-METOXI-N- (3- {4- [3-METHYL-4 (6-METHYLPIRIDIN-3-ILOXI) PHENYLAMINE] QUINAZOLIN-6-IL} ALIL) ACETAMIDE, ITS PRODUCTION AND USE PROCEDURE